- Issuer ticker
-
CRMD
- Reported as of
-
14 Jan 2023
- Net transaction value
-
$0
Source evidence
Original filing metadata and source links for verification.
4 source fields
- SEC form
-
4
- Accepted by SEC
-
18 Jan 2023, 18:04:16 UTC
Reporting owner
1 detail
- Reporting owner signature
-
/s/ Phoebe Mounts
Key filing fact
Phoebe Mounts filed Form 4 for CorMedix Inc. (CRMD) on 18 Jan 2023.
Key facts
- This page summarizes Phoebe Mounts's Form 4 filing for CorMedix Inc. (CRMD).
- 1 reported transaction and 1 derivative row are listed below.
- Accepted by SEC: 18 Jan 2023, 18:04.
Change
- Previous filing in this sequence was filed on 23 Feb 2022.
- Current net transaction value: $0.
Research use
- This tells you what this filing adds before you inspect full transaction and derivative tables.
- You can trace every row back to the original SEC filing document.
Evidence
Filed on Form 4
Ownership activity is grounded in SEC Form 4 disclosures.
View source filing
Reported non-derivative transactions
Shares, units, or other non-derivative securities reported in this filing.
CRMD
holding
Common Stock
No transaction description listed
- Transaction value
- Shares
- Change %
- Price
-
- Shares after
- 7,200
- Date
- 14 Jan 2023
- Ownership
- Direct
Reported derivative securities
Options, warrants, convertible securities, or similar derivative positions disclosed in the filing.
CRMD
transaction
Derivative
Stock Option (Right to Buy Common Stock)
Award
- Transaction value
- $0
- Shares
- +125,000
- Change %
- Price
-
$0.000000
- Shares after
- 125,000
- Date
- 14 Jan 2023
- Ownership
- Direct
- Underlying class
- Common Stock
- Underlying amount
- 125,000
- Exercise price
- $4.43
- Footnotes
- F1
* marks a reported price that did not pass the local price check.
Explanation of responses
1 footnote